Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.
Checked 2026-10-11 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.
## Key findings
- Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
- For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
- <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
- ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
- For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
- <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
- ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
- Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
- Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
- Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
- The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.
## Methods
- Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
- Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
- Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.
## Limitations
- The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
- It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
- The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI was significantly associated with breast cancer mortality.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
states an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The current systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre and postmenopausal breast cancer, regardless of when BMI is ascertained.”
- Also stated in: § discussion · boosted
“The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.”
- Also stated in: § discussion · plain
“In conclusion, the present systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with normal weight women, for BMI before diagnosis, the summary RRs were 1.35 (95% CI 1.24–1.47, 22 studies) for obese women, 1.11 (95% CI 1.06–1.17, 21 studies) for overweight women, and 1.02 (95% CI 0.85–1.21, 8 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 76 claims and to verify the 9 references still open.
- The quote only partly states this claim. 4
- It may state two separate claims as one. 16
- Probably not a substantial claim. 10
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“statistical analysis Categorical and dose-response meta-analyses were conducted using random-effects models to account for between-study heterogeneity[18].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“To assess heterogeneity, we computed the Cochran Q test and I 2 statistic[35].”
MethodFood, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · cited 1×
“be obese and 958 million were overweight in 2008[3].”
BackgroundPublication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Small study or publication bias was examined by Egger’s test[36] and visual inspection of the funnel plots.”
MethodNutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“generalised least-squares for trend estimation[25].”
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“The non-linear dose-response relationship between BMI and mortality was examined using the best-fitting second order fractional polynomial regression model[23], defined as the one with the lowest deviance.”
MethodFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962 · cited 3×
“A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”
Background
Research works printed but not linked: 2
- Tobias A Assessing the influence of a single study in meta-analysis Stata Tech Bull 1999 47 15 17
- Donegan WL Jayich S Koehler MR The prognostic implications of obesity for the surgical cure of breast cancer Breast 1978 4 14 17
Cited by
Items 301–400 of 1,000
Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast Cancer
Freedman, R. A., & Partridge, A. H. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2552 · Cited by 37
Liu, Y. L., Saraf, A., Catanese, B. P., Lee, S. M., Zhang, Y., Connolly, E. P., & Kalinsky, K. M. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4507-y · Cited by 37
“A recent meta-analysis found that although obesity is associated with worse survival overall, there may be a suggestion of larger effect size in premenopausal versus postmenopausal women [5].”
Cho, W. K., Choi, D. H., Park, W., Cha, H., Nam, S. J., Kim, S. W., Lee, J. E., Yu, J., Im, Y., Ahn, J. S., et al. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.04.010 · Cited by 37
Giallauria, F., Vitelli, A., Maresca, L., de Magistris, M. S., Chiodini, P., Mattiello, A., Gentile, M., Mancini, M. E., Grieco, A., Russo, A., et al. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1259-8 · Cited by 37
Xu, K., Fu, A., Li, Z., Miao, L., Lou, Z., Jiang, K., Lau, C., Su, T., Tong, T., Bao, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45995-5 · Cited by 36
Luque, R. M., Lopez-Sanchez, L. M., Villa-Osaba, A., Luque, I. M., Santos-Romero, A. L., Yubero‐Serrano, E. M., García, M. C., Benito, M. Á., López‐Miranda, J., Gahete, M. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20399 · Cited by 36
“Importantly, our observation could be related to the fact that the relative risk of mortality is higher in obese BCa patients compared to controls [3, 4, 28, 29].”
ResultAdipokines as therapeutic targets in breast cancer treatment
Cha, Y. J., & Koo, J. S. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1538356 · Cited by 36
Harvie, M., Pegington, M., McMullan, D., Bundred, N. J., Livingstone, K., Campbell, A., Wolstenholme, J. L., Lovato, E., Campbell, H., Adams, J. E., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0522-6 · Cited by 36
Khaddour, K., Gomez‐Perez, S. L., Jain, N., Patel, J. D., & Boumber, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.576314 · Cited by 36
“For example, systematic reviews and meta-analyses of population-based follow-up studies of obese patients with non-metastatic prostate and breast cancer across all clinical stages found a higher mortality in obese compared to normal weight patients regardless of treatment modality (4, 5).”
BackgroundDai, J., Wang, Y., Chen, C., Tsai, I., Chao, Y., & Lin, C. (2022) · Advanced Science · doi:10.1002/advs.202103687 · Cited by 36
Thill, M., Jackisch, C., Janni, W., Müller, V., Albert, U., Bauerfeind, I., Blohmer, J., Budach, W., Dall, P., Diel, I., et al. (2019) · Breast Care · doi:10.1159/000500999 · Cited by 36
Elsamany, S. A., Alzahrani, A. M., Abozeed, W. N., Rasmy, A. A., Farooq, M. U., ElBaiomy, M. A., Rawah, E., Alsaleh, K. A., & Abdel-Aziz, N. M. (2015) · The Breast · doi:10.1016/j.breast.2015.05.007 · Cited by 36
“Similarly, in a recent meta-analysis including 213,075 patients from 82 studies, obesity was associated with poor overall and breast cancer survival in pre- and post-menopausal breast cancer patients [31].”
ResultOverweight, Obesity, Oxidative Stress and the Risk of Breast Cancer
Kruk, J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.22.9579 · Cited by 36
“Obesity is a serious worldwide problem that affects of hundreds of millions of people; over 500 million adults were obese and 958 million overweight in 2008 (Chan et al., 2014).”
BackgroundThomson, Z. O., & Reeves, M. M. (2017) · Obesity Reviews · doi:10.1111/obr.12591 · Cited by 36
“Obesity increases the risk of developing postmenopausal breast cancer (2) and is associated with worse breast cancer-specific survival and all-cause mortality (3).”
BackgroundDragic, D., Ennour‐Idrissi, K., MICHAUD, A., Chang, S.-L., Durocher, F., & Diorio, C. (2020) · Anticancer Research · doi:10.21873/anticanres.14134 · Cited by 35
Ma, S. J., Khan, M., Chatterjee, U., Santhosh, S., Hashmi, M., Gill, J., Yu, B., Iovoli, A. J., Farrugia, M. K., Wooten, K. E., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.20513 · Cited by 36
The Obesity Paradox in Survival after Cancer Diagnosis: Tools for Evaluation of Potential Bias
Mayeda, E. R., & Glymour, M. M. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0559 · Cited by 35
“These findings are consistent with Kroenke and colleagues' (4) recent report that overweight colorectal cancer patients have better survival than normal weight colorectal cancer patients, but stand in contrast to some prior observational research (5) and some current survivor guidelines (6).”
ResultCereijo‐Garea, C., Pita‐Fernández, S., Nebril, B. A., Villar, R. R., Novoa, A. G., Varela‐Lamas, C., Builes‐Ramírez, S., Seoane‐Pillado, T., & Barreiro, V. B. (2018) · Journal of Clinical Nursing · doi:10.1111/jocn.14291 · Cited by 35
Rajarajan, D., Selvarajan, S., Raja, M. R. C., Mahapatra, S. K., & Kasiappan, R. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28428 · Cited by 35
“Obesity has been identified as one of the major risk factor for BCa progression, incidence, prognosis, metastasis, and recurrence (Chan et al., 2014).”
BackgroundSkyttä, T., TUOHINEN, S. S., Luukkaala, T. H., Virtanen, V., Raatikainen, P. M. J., & Kellokumpu‐Lehtinen, P. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1630751 · Cited by 35
Ketogenic diet and cancer: Fad or fabulous?
Mundi, M. S., Elfadil, O. M., Patel, I. K., Patel, J., & Hurt, R. T. (2021) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2226 · Cited by 35
Hyperinsulinemia in Obesity, Inflammation, and Cancer
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0131 · Cited by 36
Chasimpha, S., McCormack, V., Cubasch, H., Joffe, M., Zietsman, A., Galukande, M., Parham, G. P., Pinder, L. F., Anele, A., Adisa, C. A., et al. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(21)00326-x · Cited by 35
The role of obesity and bariatric surgery-induced weight loss in breast cancer
Bohm, M. S., Sipe, L. M., Pye, M. E., Davis, M. J., Pierre, J. F., & Makowski, L. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10050-6 · Cited by 35
Efficacy of Complementary Therapies in the Quality of Life of Breast Cancer Survivors
Zaidi, S., Hussain, S., Verma, S., Veqar, Z., Khan, A., Nazir, S. U., Singh, N., Moiz, J. A., Tanwar, P., Srivastava, A., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2017.00326 · Cited by 35
“A 35% higher risk of BC-related death and a 41% higher risk of death due to other causes (96) have been noted in patients with obesity.”
BackgroundTravier, N., Buckland, G., Vendrell, J. J., Fernández‐Veledo, S., Peiró, I., Barco, S. D., Pernas, S., Zamora, E., Bellet, M., Vila, M. M., et al. (2018) · European Journal of Cancer Care · doi:10.1111/ecc.12861 · Cited by 35
Resolution of chronic inflammation and cancer
Tezcan, G., Yakar, N., Hastürk, H., Dyke, T. E. V., & Kantarcı, A. (2024) · Periodontology 2000 · doi:10.1111/prd.12603 · Cited by 34
Sun, X., Nichols, H. B., Robinson, W. R., Sherman, M. E., Olshan, A. F., & Troester, M. A. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0673-6 · Cited by 34
“meta-analysis shows that in comparison with lean patients, obese patients had 41 and 35 % higher risk of all-cause deaths and breast cancer (BC)-specific deaths, respectively [1].”
InfluentialLote, H., Sharp, A., Redana, S., Papadimitraki, E., Capelán, M., & Ring, A. E. (2016) · Clinical Oncology · doi:10.1016/j.clon.2016.02.003 · Cited by 34
American Society of Clinical Oncology Obesity Initiative: Rationale, Progress, and Future Directions
Ligibel, J. A., & Wollins, D. S. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.4051 · Cited by 34
Jacot, W., Arnaud, A., Jarlier, M., Lefeuvre‐Plesse, C., Dalivoust, P., Sénesse, P., Azzedine, A., Trédan, O., Sadot‐Lebouvier, S., Mas, S., et al. (2020) · Nutrients · doi:10.3390/nu12103081 · Cited by 34
“This is a particularly relevant effect in the clinical context of BC, as body mass index (BMI) before and after BC diagnosis, and weight gain after diagnosis were associated with increased mortality in recent meta-analyses [7,8].”
BackgroundAlmekinders, M. M., Schaapveld, M., Thijssen, B., Visser, L. L., Bismeijer, T., Sanders, J., Isnaldi, E., Hofland, I., Mertz, M., Wessels, L. F. A., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00232-w · Cited by 34
Abraham, J., Hiller, L., Dorling, L., Vallier, A.-L., Dunn, J., Bowden, S. J., Ingle, S., Jones, L., Hardy, R. M., Twelves, C., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0547-5 · Cited by 34
“Given the known association of increasing BMI with poor prognosis [17, 18], we repeated the analysis adjusting for BMI, to confirm that the relationship between neutropenia and RFS/BCSS was independent of BMI.”
MethodMatsui, C., Takatani‐Nakase, T., Hatano, Y., Kawahara, S., Nakase, I., & Takahashi, K. (2017) · FEBS Letters · doi:10.1002/1873-3468.12797 · Cited by 34
Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico
Rojas, C., Álvarez-Bañuelos, M. T., Morales‐Romero, J., Suárez-Díaz, H., Hernández-Fonseca, J. C., & Contreras-Alarcón, G. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.08.003 · Cited by 34
“- Clinical Breast Cancer February 2019 hormonal pathways.(4,5,8-11) The distinct molecular subtypes result in marked differences depending on the ethnic group.”
Anderson, C., Harrigan, M., George, S. M., Ferrucci, L. M., Sanft, T. B., Irwin, M. L., & Cartmel, B. (2016) · npj Breast Cancer · doi:10.1038/npjbcancer.2016.26 · Cited by 33
Lawler, S., Maher, G., Brennan, M. E., Goode, A. D., Reeves, M. M., & Eakin, E. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3599-6 · Cited by 33
The Impact of Bariatric Surgery on Breast Cancer Recurrence: Case Series and Review of Literature
Zhang, S., Ikramuddin, S., Beckwith, H. C., Sheka, A. C., Wirth, K. M., & Blaes, A. H. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04099-6 · Cited by 33
Association between diabetes, obesity, aging, and cancer: review of recent literature
Qiang, J. K., Lipscombe, L. L., & Lega, I. C. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.14 · Cited by 33
“47), respectively, compared to women with normal weight (82).”
BackgroundWang, J., Cai, Y., Yu, F., Ping, Z., & Liu, L. (2020) · BMC Cancer · doi:10.1186/s12885-020-07064-0 · Cited by 33
“Furthermore, women who are obese with breast cancer diagnosis were reported to have greater disease mortality, higher recurrence rate and adverse overall and diseasefree survival [18, 19].”
BackgroundYin, L., Song, C., Cui, J., Wang, N., Fan, Y., Lin, X., Zhang, L., Zhang, M., Wang, C., Liang, T., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.026 · Cited by 33
Trinkner, P., Günther, S., Monsef, I., Kerschbaum, E., von Bergwelt‐Baildon, M., dos Santos, D. M. C., & Theurich, S. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.01.030 · Cited by 33
Why does obesity promote cancer? Epidemiology, biology, and open questions
Mazzarella, L. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.554 · Cited by 34
Kakugawa, Y., Tada, H., Kawai, M., Suzuki, T., Nishino, Y., Kanemura, S., Ishida, T., Ohuchi, N., & Minami, Y. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4094-3 · Cited by 33
Lee, K. N., Torres, M. A., Troeschel, A. N., He, J., Gogineni, K., & McCullough, L. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232581 · Cited by 33
Obesity-Associated Breast Cancer: Analysis of Risk Factors and Current Clinical Evaluation
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_26 · Cited by 32
Cosimo, S. D., Porcu, L., Agbor‐Tarh, D., Cinieri, S., Franzoi, M. A., Santis, M. C. D., Saura, C., Huober, J., Fumagalli, D., Izquierdo, M. A., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01356-w · Cited by 32
Delahanty, L. M., Wadden, T. A., Goodwin, P. J., Alfano, C. M., Thomson, C. A., Irwin, M. L., Neuhouser, M. L., Crane, T. E., Frank, E. S., Spears, P. A., et al. (2021) · Obesity · doi:10.1002/oby.23287 · Cited by 32
Rebeaud, M., Bouche, C., Dauvillier, S., Attané, C., Arellano, C., Vaysse, C., Fallone, F., & Muller, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-31673-x · Cited by 32
Obesity, insulin resistance and breast cancer outcomes
Goodwin, P. J. (2015) · The Breast · doi:10.1016/j.breast.2015.07.014 · Cited by 32
Bergom, C. R., Kelly, T. R., Bedi, M., Saeed, H., Prior, P., Rein, L., Szabó, A., Wilson, J. F., Currey, A. D., & White, J. R. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.04.020 · Cited by 32
Anderson, A. S., Caswell, S., Macleod, M., Steele, R. J., Berg, J. N., Dunlop, J., Stead, M., Eadie, D. R., & O’Carroll, R. E. (2016) · Journal of Genetic Counseling · doi:10.1007/s10897-016-9977-2 · Cited by 32
“In patients who go on to develop cancer, post operative complications associated with smoking have been well described but is also noteworthy that obesity is associated with poorer prognosis, increases in disease recurrence and overall mortality (Meyerhardt et al. 2003; Chan et al. 2014).”
BackgroundBody Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer
Warren, L. E., Ligibel, J. A., Chen, Y., Truong, L., Catalano, P. J., & Bellon, J. R. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5437-3 · Cited by 32
“Whereas some reports suggest that the relationship of BMI to breast cancer-specific survival and OS may be stronger in premenopausal women,(5,6) recent meta-analyses support the relationship between BMI at the time of cancer diagnosis and outcomes in both pre- and postmenopausal women.(10,22) Our study observed a rela…”
ResultSun, X., Gupta, K., Wu, B., Zhang, D., Yuan, B., Zhang, X., Chiang, H.-C., Zhang, C., Curiel, T. J., Bendeck, M. P., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000672 · Cited by 32
Early breast cancer: why does obesity affect prognosis?
Heetun, A., Cutress, R., & Copson, E. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118000447 · Cited by 32
“Each additional 5 kg/m(2) BMI before diagnosis was associated with a 17 % increase in total mortality and a 18 % increase in breast cancer mortality (11 % increase in total mortality and 14 % increase in breast cancer mortality at <12 months from diagnosis and 8 and 29 %, respectively, at >12 months from diagnosis)((6…”
InfluentialWarr, C. G., Shaw, K. H., Azim, A., Piper, M. D. W., & Parsons, L. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124110 · Cited by 32
“In breast cancer, excess weight and obesity also drive cancer progression, and are associated with recurrence [18,19], metastasis to bone and poor response to chemotherapeutic agents [20].”
BackgroundThe Obesity Paradox and Mortality After Colorectal Cancer: A Causal Conundrum
Renehan, A. G., & Sperrin, M. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0868 · Cited by 32
Predictive and prognostic value of prognostic nutritional index for locally advanced breast cancer
Wang, Y., Battseren, B., Yin, W., Lin, Y., Zhou, L., Yang, F., Wang, Y., Sun, L., & Lu, J. (2019) · Gland Surgery · doi:10.21037/gs.2019.10.08 · Cited by 31
“53) increased the risk of breast cancer death (24).”
BackgroundMartinez‐Tapia, C., Diot, T., Oubaya, N., Paillaud, É., Poisson, J., Gisselbrecht, M., Morisset, L., Caillet, P., Baudin, A., Pamoukdjian, F., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa238 · Cited by 31
Bandera, E. V., Alfano, C. M., Qin, B., Kang, D., Friel, C. P., & Dieli-Conwright, C. M. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_321315 · Cited by 31
Self-citationScully, T., KASE, N. G., Gallagher, E. J., & LeRoith, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-97327-y · Cited by 31
“(1) EGF stimulation of the EGF receptor leads to dimerization and phosphorylation of the EGFR.”
BackgroundYin, L., Zhang, L., Li, N., Guo, J., Liu, L., Lin, X., Fan, Y., Liu, J., Zhang, M., Chong, F., et al. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-01009-x · Cited by 31
Flore, G., Deledda, A., Lombardo, M., Armani, A., & Velluzzi, F. (2023) · Antioxidants · doi:10.3390/antiox12101845 · Cited by 31
“The risk is higher when the increase exceeds 10% of weight at diagnosis [27,59,61,62].”
BackgroundGoodwin, P. J., Ambrosone, C. B., & Hong, C. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16366-6_12 · Cited by 31
Excess body weight and colorectal cancer survival: the multiethnic cohort
Maskarinec, G., Harmon, B. E., Little, M. A., Ollberding, N. J., Kolonel, L. N., Henderson, B. E., Marchand, L. L., & Wilkens, L. R. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0664-7 · Cited by 31
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials
Yerushalmi, R., Dong, B., Chapman, J. W., Goss, P. E., Pollak, M., Burnell, M. J., Levine, M. N., Bramwell, V. H. C., Pritchard, K. I., Whelan, T. J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx152 · Cited by 31
Schraa, S. J., Frerichs, K., Agterof, M. J., Hunting, J. C. B., Los, M., & de Jong, P. C. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.04.001 · Cited by 31
Andò, S., Naimo, G. D., Gelsomino, L., Catalano, S., & Mauro, L. (2020) · Obesity Reviews · doi:10.1111/obr.13004 · Cited by 30
Molecular insights into the interplay between adiposity, breast cancer and bone metastasis
Soni, S., Torvund, M., & Mandal, C. C. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10076-0 · Cited by 30
A Review of Breast Cancer Risk Factors in Adolescents and Young Adults
McVeigh, U. M., Tepper, J. W., & McVeigh, T. P. (2021) · Cancers · doi:10.3390/cancers13215552 · Cited by 30
The Challenges of Treating Patients with Breast Cancer and Obesity
LeVee, A. A., & Mortimer, J. E. (2023) · Cancers · doi:10.3390/cancers15092526 · Cited by 30
“Ultimately, women with obesity and breast cancer have a 60% increased risk of dying of cardiovascular disease after breast cancer diagnosis compared to women with normal weight, and a 41% increased risk of dying of all-cause mortality [9].”
BackgroundGevorgyan, A., Bregni, G., Galli, G., Ganzinelli, M., Martinetti, A., Vullo, S. L., Mariani, L., Festinese, F., Sottotetti, E., de Braud, F., et al. (2016) · Tumori Journal · doi:10.5301/tj.5000515 · Cited by 30
“Possible confounding factors, such as chemotherapy underdosing and concurrent illnesses, were also analyzed and ruled out (11).”
BackgroundUeno, A., Yamaguchi, K., Sudo, M., & Imai, S. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-019-05279-x · Cited by 30
Beneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer
Anastasiou, I. A., Kounatidis, D. C., Vallianou, N. G., Skourtis, A., Dimitriou, K., Tzivaki, I., Tsioulos, G., Rigatou, A., Karampela, Ι., & Dalamaga, Μ. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01654-6 · Cited by 29
“Obesity raises the risk of all-cause and breast cancer-specific mortality by 35% and 41%, respectively, according to a meta-analysis of 82 studies on breast cancer survivors [99].”
The Effects of Obesity on Lymphatic Pain and Swelling in Breast Cancer Patients
Fu, M. R., Axelrod, D., Guth, A. A., McTernan, M. L., Qiu, J. M., Zhou, Z., Ko, E., Magny‐Normilus, C., Scagliola, J., & Wang, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9070818 · Cited by 29
Lisevick, A. B., Cartmel, B., Harrigan, M., Li, F., Sanft, T. B., Fogarasi, M. C., Irwin, M. L., & Ferrucci, L. M. (2021) · Nutrients · doi:10.3390/nu13093265 · Cited by 29
Liver Metastatic Breast Cancer: Epidemiology, Dietary Interventions, and Related Metabolism
Zuo, Q., Park, N. H., Lee, J. K., & Madak‐Erdogan, Z. (2022) · Nutrients · doi:10.3390/nu14122376 · Cited by 29
Mantzorou, M., Tolia, M., Poultsidi, A., Vasios, G. K., Papandreou, D., Theocharis, S. E., Kavantzas, N., Troumbis, A. Y., & Giaginis, C. (2022) · Current Oncology · doi:10.3390/curroncol29100589 · Cited by 29
“More specifically, obesity is associated with shorter overall and cancer-specific survival, and being overweight is associated with higher overall survival [62].”
BackgroundBerkman, A. M., Brewster, A. M., Jones, L. W., Yu, J. Q., Lee, J. J., Peng, S. A., Crocker, A. M., Ater, J. L., & Gilchrist, S. C. (2017) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2017.0024 · Cited by 29
Enhancement of mammary tumour growth by IGFBP-3 involves impaired T cell accumulation
Scully, T., Scott, C. D., Firth, S. M., Sedger, L. M., Pintar, J. E., Twigg, S. M., & Baxter, R. C. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0384 · Cited by 29
Park, S., Knobf, M. T., Kerstetter, J. E., & Jeon, S. (2018) · Cancer Nursing · doi:10.1097/ncc.0000000000000602 · Cited by 29
Lahiji, M. R., Najafi, S., Janani, L., Yazdani, B., Razmpoosh, E., & Zarrati, M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.05.043 · Cited by 29
Cancer du sein, obésité et tissu adipeux: Un trio à haut risque
Fallone, F., Deudon, R., Muller, C., & Vaysse, C. (2018) · médecine/sciences · doi:10.1051/medsci/2018298 · Cited by 29
Ko, S. M., Lee, J., Bae, S. J., Baik, S. J., Ji, J., Kim, D., Ahn, S. G., & Jeong, J. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01391-0 · Cited by 29
“argued that obesity is associated with poor OS and breast cancer-specific survival (BCSS) in breast cancer patients in their systemic literature review of 82 follow-up studies.(15) In this meta-analysis, the relative risk (RR) of total mortality in obese women was 1.”
BackgroundPostoperative BMI Loss at One Year Correlated with Poor Outcomes in Chinese Gastric Cancer Patients
Wang, N., Jiang, J., Xi, W., Wu, J., Zhou, C., Shi, M., Wang, C., Zhu, Z., Liu, J., & Zhang, J. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.46530 · Cited by 28
“Obesity is an established risk factor for at least 17 different types of cancers, and portends less favorable outcomes in several cancers [4-6].”
BackgroundCardaci, T. D., VanderVeen, B. N., Bullard, B. M., McDonald, S. J., Unger, C. A., Enos, R. T., Fan, D., Velázquez, K. T., Frizzell, N., Spangenburg, E. E., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13391 · Cited by 28
Kristensson, F. M., Andersson‐Assarsson, J. C., Peltonen, M., Jacobson, P., Ahlin, S., Svensson, P., Sjöholm, K., Carlsson, L. M. S., & Taube, M. (2024) · JAMA Surgery · doi:10.1001/jamasurg.2024.1169 · Cited by 28
High prevalence of vitamin D deficiency in women with breast cancer: The first Chilean study
Acevedo, F., Pérez, V., Pérez‐Sepúlveda, A., Florenzano, P. F., Artigas, R., Medina, L., & Sanchez, C. G. (2016) · The Breast · doi:10.1016/j.breast.2016.06.022 · Cited by 28
The Association Between Body Size and Breast Cancer in Han Women in Northern and Eastern China
Wang, X., Li, L., Gao, J., Liu, J., Guo, M., Liu, L., Wang, J., Wang, J., Xing, Z., Yu, Z., et al. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0147 · Cited by 28
The Impact of Diet on Breast Cancer Outcomes
Xu, L., & Peterson, L. L. (2019) · Current Nutrition Reports · doi:10.1007/s13668-019-00278-0 · Cited by 28
Vernaci, G. M., Dieci, M. V., Manfrin, S., Mantiero, M., Falci, C., Faggioni, G., Mioranza, E., Menichetti, A., Tasca, G., Griguolo, G., et al. (2019) · The Breast · doi:10.1016/j.breast.2019.07.003 · Cited by 28
Meglio, A. D., Michiels, S., Jones, L. W., Mouhebb, M. E., Ferreira, A. R., Martin, É., Matias, M., Lohmann, A. E., Joly, F., Vanlemmens, L., et al. (2020) · The Breast · doi:10.1016/j.breast.2020.04.002 · Cited by 28
“Compelling evidence points at the strong link between obesity and breast cancer: excess weight represents a risk factor for postmenopausal breast cancer [3], increases the risk of recurrent and second primary breast cancer [4] and that of overall and breast cancer-specific mortality [5].”
BackgroundMartel, S., Lambertini, M., Agbor‐Tarh, D., Ponde, N. F., Gombos, A., Paterson, V., Hilbers, F., Korde, L. A., Manukyants, A., Dueck, A. C., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7606 · Cited by 28
“Surgery 2 (2) 120 (6) 81 (6) 81 (9) Radiation 0 2 (,1) 5 (,1) 2 (,1)”
InfluentialDistinct Metabolism of Bone Marrow Adipocytes and their Role in Bone Metastasis
Li, Y., Cao, S., Gaculenko, A., Zhan, Y., Bözec, A., & Chen, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.902033 · Cited by 27
Savva, C., Copson, E., Johnson, P., Cutress, R., & Beers, S. A. (2023) · Cancers · doi:10.3390/cancers15092440 · Cited by 27
“Overweight and obesity not only increase the risk of developing BC but also are associated with worse survival compared to patients with normal weight [4,5].”
BackgroundA high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia
Crysandt, M. M., Krämer, M., Ehninger, G., Bornhäuser, M., Berdel, W. E., Serve, H. L., Röllig, C., Kaifie, A., Jost, E., Brümmendorf, T. H., et al. (2015) · European Journal Of Haematology · doi:10.1111/ejh.12675 · Cited by 27
Dittus, K. L., Harvey, J. R., Bunn, J. Y., Kokinda, N., Wilson, K. M., Priest, J. S., & Pratley, R. E. (2018) · BMC Cancer · doi:10.1186/s12885-018-4272-2 · Cited by 27
Bang, J.-I., Yoon, H., & Kim, B. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208861 · Cited by 27
Dietary fat and obesity as modulators of breast cancer risk: Focus on DNA methylation
Donovan, M. G., Wren, S. N., Cenker, M., Selmin, O. I., & Romagnolo, D. F. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14891 · Cited by 27
“Obesity is associated with worse overall survival (OS), but not with BC-specific survival (Chan et al., 2014; Mei et al., 2018; Niraula, Ocana, Ennis, & Goodwin, 2012; Playdon et al., 2015).”
BackgroundKoh, D., Song, S., Moon, S.-E., Jung, S., Lee, E. S., Kim, Z., Youn, H. J., Cho, J., Yoo, Y. B., Lee, S. K., et al. (2019) · Nutrients · doi:10.3390/nu11122924 · Cited by 27
“As both underweight [33] and obesity [34] have been suggested to worsen the prognosis of breast cancer patients, we assigned the lowest score to <18.”
Background
Metadata
- Authors
- Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
- Affiliations
- Imperial College London (GB)
- Norwegian University of Science and Technology (NO)
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Fred Hutch Cancer Center (US)
- Oslo University Hospital (NO)
- Newcastle University (GB)
- Corresponding author
- Chan, D.S.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 25
- Issue
- 10
- Pages
- 1901-1914
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4176449
- OpenAlex
- W2149466392
- Cited by
- 1,165
- References
- 123
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1878 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- World Cancer Research Fund International (2007/SP01)
- World Cancer Research Fund International/American Institute for Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
- MeSH terms
- Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.